Characterization of a liver metastatic variant of murine K1735M2 melanoma cells

In Vivo

Volumn 14, Issue 4, 2000, Pages 519-527

  Ikeda, T ^a   Murakami, K ^a   Sakukaw, R ^a   Hayakawa, Y ^a   Saiki, I ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Invasion; K1735M2L5; Liver metastasis; Melanoma

Indexed keywords

BETA1 INTEGRIN; FIBRONECTIN; LAMININ; MATRIGEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; DEGRADATION; FEMALE; IN VITRO STUDY; LIVER METASTASIS; MELANOMA CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE;

EID: 0033852424     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. 'Seed and soil' revisited: Mechanisms of site specific metastasis
2. Tumor invasion and the extracellular matrix
3. The Ernst W. Bertner Memorial Award Lecture: The evolution of biological heterogeneity in metastatic neoplasms
4. Tumor cell instability, diversification, and progression to the metastatic phenotype: From oncogene to oncofetal expression
5. Heterogeneous mechanism of tumor cell-induced platelet aggregation with possible strategy toward prevention of metastasis
6. Laminin and fibronectin promote the haptotactic migration of B16-BL6 mouse melanoma cells in vitro
7. Basement membrane and the invasive activity of metastatic tumor cells
8. Epidemiology of preinvasive and invasive malignant melanoma in Western Australia
9. Effect of ultraviolet-B radiation on the in vivo growth of murine melanoma cells
10. Cutaneous melamoma
11. Selection of successive tumour lines for metastasis
12. Recombinant fusion polypeptide with cell- and heparin-binding domains of fibronectin inhibits liver metastasis of L5178Y-ML25 lymphoma cells
13. Synthetic Arg-Gly-Asp-Ser analogues of the cell recognition site of fibronectin that retain antimetastatic and anti-cell adhesive properties
14. Activity of type IV collagenases in benign and malignant breast disease
15. A modified invasion- 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide assay for quantitating tumor cell invasion
16. Inhibition of tumor cell invasion by ubenimex (bestatin) in vitro
17. Inhibition of lung metastasis by synthetic and recombinant fragments of human fibronectin with functional domains
18. 4-[3,5-Bis(trimethylsilyl) benzamido] benzoic acid (TAC-101) inhibits the intrahepatic spread of hepatocellular carcinoma and prolongs the life-span tumor-bearing animals
19. Tumor invasion and metastases-role of the extracellular matrix: Rhoads Memorial Award lecture
20. Involvement of PA/plasmin system in the processing of pro-MMP and in the second step of pro-MMP-2 activation
21. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin
22. Immediate early detection of urokinase receptor after partial hepatectomy and its implications for initiation of liver regeneration
23. Activation of hepatocyte growth factor by proteolytic conversion of a single chain form to a heterodimer
24. Analysis of the role of the COOH-terminal domain in the activation, proteolytic activity, and tissue inhibitor of metalloproteinase interactions of gelatinase B
25. The urokinase- type plasminogen activator system in cancer metastasis: A review
26. Proteolytic enzyme activity in stomach cancer patients with various prognoses
27. Plasminogen activator and matrix metalloproteinase production and extracellular matrix degradation by rat prostate cancer cells in vitro
28. Biochemical interactions of tumor cells with the basement membrane
29. Changes in integrin receptors oncogenically transformed cells
30. Heterogeneity for integrin expression and cytokine-mediated VLA modulation can influence the adhesion of human melanoma cells to extracellular matrix proteins
31. Alterations in integrin receptor expression on chemically transformed human cells: Specific enhancement of laminin and collagen receptor complexes
32. Laminin receptor on platelets is the integrin VLA-6
33. Inhibition of binding of fibronectin to matrix assembly sites by anti-integrin (aipha 5 beta 1) antibodies
34. Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin
35. Identification of a novel recognition sequence for the integrin alpha 4 beta 1 in the COOH-terminal heparin-binding domain of fibronectin
36. Adhesion molecules in tumor metastasis
37. Involvement of tumor necrosis factor alpha and very late activation antigen 4/vascular cell adhesion molecule 1 interaction in surgical stress-enhanced experimental metastasis
38. The disintegrin eristostatin interferes with integrin alpha 4 beta 1 function and with experimental metastasis of human melanoma cells
39. Integrin expression in cutaneous malignant melanoma: Association of the alpha 3/beta 1 heterodimer with tumor progression
40. Cadherins in cancer: Implications for invasion and metastasis
41. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas
42. Mutations of the E-cadherin gene in human gynecologic cancers
43. E-cadherin expression in primary and metastatic thoracic neoplasms and in Barrett's oesophagus
44. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis
45. Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features
46. E-cadherin expression in squamous cell carcinomas of head and neck
47. Level of expression of E-cadherin in colorectal cancer correlates with clinical outcome
48. Type IV collagenases in tumor invasion and metastasis
49. Tumor-associated urokinase-type plasminogen activator: Biological and clinical significance
50. Metastatic potential correlates with enzymatic degradation of basement membrane collagen
51. Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma
52. Molecular mechanisms of melanoma metastasis
53. Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells